Navigation Links
Chronic Sinusitis Resulting From Weakene Immune System

Suppressed activity of several key chemicals on the inner lining of the nose are linked to chronic sinusitis that fails to respond to the usual current treatments according// to researchers at John Hopkins University.

An estimated 32 million Americans know the misery of persistent inflammation of the moist tissue that lines the nose and sinus cavities. The result is clogged passages and recurring infections, according to the U.S. Centers for Disease Control and Prevention.

Because nearly one in 10 of those treated see symptoms return within weeks or months after drugs or surgery fail to keep the sinus passages open, scientists have long suspected that these resistant cases had some underlying problem with the immune system contributing to the ailment.

In a study to be described on Sept. 19 at the annual scientific sessions of the American Academy of Otolaryngology, Head and Neck Surgery, the Hopkins team found that in chronic sufferers who failed to respond to treatment, the activity of at least four genes in the body's nasal immune defense system were severely decreased, and their production of two proteins critical to this defense was 20 to 200 times less than normal.

Comparing nasal epithelial cell samples from nine patients who benefited from surgery with nine who did not, the Hopkins team discovered suppressed levels of human beta defensin 2 (HBD2) and mannose binding lectin (MBL) in those whose symptoms returned. The proteins are naturally produced in the nose whenever the immune system detects foreign bacteria or fungi, binding to invading pathogens, inactivating them and making them easily disposed of.

An earlier study published by the same team in the March-April issue of the American Journal of Rhinology also showed that sinus tissue from people with chronic sinusitis that resisted treatment had 30 times lower than normal activity of a so-called toll-like receptor gene, TLR9.

Inside t
'"/>




Page: 1 2 3

Related medicine news :

1. Roller coasters – cause “Chronic Headache?
2. In Chronic Diseases - Poor compliance of Patients with drug treatment
3. New Treatment for Chronic Eczema
4. Novel Therapy for Chronic Problem
5. Overcoming Chronic Fatigue
6. Chronic Fatigue, Pain Linked to Sinusitis
7. Chronic Diseases said to Cause Falls in the Elderly
8. Epilepsy Drug May Relieve Chronic Headaches
9. Women Worse Affected By Chronic Cough
10. A Drug That Might Relieve Chronic Cough
11. A Sedentary Childhood Could Lead To Chronic Fatigue Latter In Life
Post Your Comments:
(Date:12/5/2009)... of International Solutions, an innovative new international private medical insurance plan ... addition to offering customers the flexibility to add or remove a ... Solutions enables customers to tailor their benefits to complement those already ... ...
(Date:12/5/2009)... popping up in the most unusual places, and to do everything from ... ... December 5, 2009 -- Who would have thought that your wine, water ... Worth, Texas has announced a new line of turbines, for industry end ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... has won the Patient,s Choice Award as the favorite ... conducted by the online website, www.weedmaps.com. Despite ... has selected Medithrive as the preeminent location for accessing ... popularity of Medithrive confirms the obvious: a dispensary which ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... one of two classes of available drugs is a cost-effective ... are likely a better bet. // ,Researchers compared the ... adults with the flu or a flu-like illness. The strategies ... treatment with an anti-flu drug, and treating patients without testing., ...
... High blood pressure is becoming more common around the world. ... ,Many guidelines currently call for anywhere between half an ... of the week to reduce the risk of heart disease, ... women who had high blood pressure but were otherwise healthy. ...
... that sage can significantly improve memory.,New research shows a ... Alzheimer's disease. // ,A team of researchers tested ... Some were given sage oil capsules, and some were ... took the sage oil performed significantly better than those ...
... a new way to treat certain kinds of cancer ... far more high-energy radioactivity than current radio-isotopes used to ... invade bone marrow. For many years, doctors have used ... metastases. ,The radio-isotopes ease pain by accumulating in ...
... A non-surgical dental procedure -- known as scaling and root ... pregnant women with periodontal disease, //according to a new study. ... of dentistry studied more than 350 pregnant women who had ... supporting bone that hold teeth in the mouth. Study participants ...
... It appears one of the most devastating diseases to hit ... from the Rush Institute //on Healthy Aging say it is ... use of public health planning. Current estimates vary depending on ... the United States Census as the scaffold to build upon., ...
Other Medicine News:
(Date:12/4/2009)... Imaging (TDI), part of a Health & Wellness ... superior quality infrared imaging of the breast, neuromuscular ... assist in the early diagnosis of problems associated ... imaging cameras that "read" the entire infrared range ...
(Date:12/4/2009)... Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that ... Phase II-b, dose escalation, clinical trial in Switzerland for ... Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ... the outcome of patients with severe TBI. We hope ...
(Date:12/4/2009)... 4 Hospira, Inc. (NYSE: HSP ), ... today announced the launch of its next-generation 50 mL ... and solutions, and now offers a complete size range ... responsible VisIV product. The launch of the 50 mL ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 1RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 2RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4
... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...
... Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus ... BD Diagnostics, a segment,of BD (Becton, Dickinson and Company) ... a 510(k) submission to the U.S. Food and Drug ... assay. This will,be the first assay for rapid and ...
Other Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery 2BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery 3
The Tissue Cassette Storage Cabinet is made of strong, laminated fiberboard....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Scienceware® Slide Tray Cabinet holds twelve Scienceware® H44581 microscope trays horizontally in a dust free enclosure....
Compact storage cabinets for 35 mm slides....
Medicine Products: